New drug aims to keep opioids out of C-Section recovery
NCT ID NCT07534709
First seen Apr 23, 2026 · Last updated May 01, 2026 · Updated 3 times
Summary
This study tests whether adding suzetrigine to standard pain management helps women avoid taking opioids after a C-section. About 90 women will receive either the drug or a placebo, and researchers will track how many stay opioid-free for 72 hours after surgery. The goal is to reduce opioid use while still controlling pain effectively.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CESAREAN SECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Texas at Austin Dell Medical School, Department of Women's Health
Austin, Texas, 78705, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.